EMT Marker / Epithelial to Mesenchymal Transition Marker Panel (ab216833)
Cancers | Free Full-Text | Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
Multiparameter Analysis, including EMT Markers, on Negatively Enriched Blood Samples from Patients with Squamous Cell Carcinoma of the Head and Neck | PLOS ONE
Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing | PNAS
Epithelial-Mesenchymal Transition (EMT) IF Antibody Sampler Kit | Cell Signaling Technology
Epithelial-mesenchymal transition markers screened in a cell-based model and validated in lung adenocarcinoma | BMC Cancer | Full Text
Epithelial-Mesenchymal Transition (EMT) Antibody Sampler Kit | Cell Signaling Technology
Expression of EMT markers in M14 cell clones. Protein extracts from... | Download Scientific Diagram
Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis | Nature Communications
EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration - ScienceDirect
Identification of EMT signaling cross-talk and gene regulatory networks by single-cell RNA sequencing | PNAS
Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks | Cell Death Discovery
Targeting EMT in Cancer with Repurposed Metabolic Inhibitors: Trends in Cancer
Epithelial-Mesenchymal Transition (EMT) Antibody Sampler Kit | Cell Signaling Technology
EMT & Stemness FAQs
Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC) | Scientific Reports
EMT, MET, Plasticity, and Tumor Metastasis: Trends in Cell Biology
Linking EMT programmes to normal and neoplastic epithelial stem cells | Nature Reviews Cancer
Epithelial-Mesenchymal Transition (EMT) Antibody Sampler Kit | Cell Signaling Technology
Wnt/β-Catenin Activated Targets Antibody Sampler Kit | Cell Signaling Technology
Frontiers | Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors
